Navigation Links
Global Transdermal Drug Delivery Market 2014-2018: Key Vendors are ANI Pharmaceuticals, Antares Pharma, Bayer, Janssen and Novartis
Date:8/7/2014

DUBLIN, Aug. 7, 2014 /PRNewswire/ -- Research and Markets has announced the addition of the "Global Transdermal Drug Delivery Market 2014-2018" report to their offering.

http://photos.prnewswire.com/prnh/20130307/600769

Transdermal drug delivery is a large and growing vertical market of the Pharmaceutical industry. Transdermal drug delivery is defined as a system that utilizes skin as a site for continuous drug administration into the systemic circulation. Several methods of transdermal drug delivery include plasters, various ointments and, most commonly, patches. Transdermal drug administration has several advantages.

First, the method of delivery is non-invasive, which is much less traumatic to the patient as compared to other forms of drug delivery. Also, it can be effective in assuring that a patient receives a full dosage of a drug and helps in increasing the compliance rate. However, there are difficulties associated with administering medication through the skin. The natural function of the skin is to act as a protective barrier, so it is often the case that drugs are not chemically suitable to penetrating the skin.

Key Topics Covered:

01. Executive Summary

02. List of Abbreviations

03. Scope of the Report

04. Market Research Methodology

05. Introduction

06. Market Landscape

07. Competitive Assessment of Transdermal Drugs Delivery Market

08. Optimisation of Transdermal Drug Delivery

09. Market Segmentation by Application

10. Geographical Segmentation

11. Buying Criteria

12. Market Growth Drivers

13. Drivers and their Impact

14. Market Challenges

15. Impact of Drivers and Challenges

16. Market Trends

17. Trends and their Impact

18. Vendor Landscape

19. Key Vendor Analysis

20. Other Reports in this Series

Companies Mentioned:

  • ANI Pharmaceuticals Inc.
  • Antares Pharma Inc.
  • Bayer AG
  • Janssen Pharmaceuticals Inc.
  • Novartis AG
  • 3M Pharmaceuticals Co.
  • Durect Corp.
  • Iontera Inc.
  • Isis Biopolymer Inc.
  • LTS Lohmann Therapie-Systeme AG
  • Mylan Laboratories Inc.
  • Nitto Denko Corp.
  • Pantec Biosolutions AG
  • Phosphagenics Ltd.
  • Tesa Labtec GmbH
  • Teva Pharmaceutical Industries Ltd.

For more information visit http://www.researchandmarkets.com/research/dj2pc6/global

Media Contact: Laura Wood, +353-1-481-1716, press@researchandmarkets.net


'/>"/>
SOURCE Research and Markets
Copyright©2014 PR Newswire.
All rights reserved

Related medicine technology :

1. Global Hemoglobin A1c Testing Devices (Ion-Exchange HPLC, Immunoassay, Boronate Affinity Chromatography, Direct Enzymatic Assay) Market - Forecast to 2019
2. Global Safety Syringes (Automatic Retractable Safety Syringes, Manual Retractable Safety Syringes, Non-Retractable Safety Syringes) Market - Forecast to 2019
3. Enteral Feeding Devices Market (Enteral Feeding Tubes, Enteral Feeding Pumps, Administration Reservoir, Giving Sets and Enteral Syringes) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
4. Orthopedic Soft Tissue Repair Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
5. Antibacterial Drugs Market (By Class and Pipeline Analysis) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
6. Global Digital X-ray (Floor to ceiling mounted, Ceiling mounted, Handheld) Market - Forecast to 2018
7. Global Patient Safety Highlighted by NABP, Domestic and International Stakeholders at .Pharmacy Supporter Advisory Committee Meeting
8. Myalgia Global Clinical Trials Review, H2, 2014
9. Myoclonus Global Clinical Trials Review, H2, 2014
10. Neuralgia Global Clinical Trials Review, H2, 2014
11. Multiple Sclerosis Global Clinical Trials Review, H2, 2014
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/5/2016)... Ala. , Feb. 5, 2016  Patients in ... high intensity focused ultrasound (HIFU) therapy no longer have to ... to announce its partnership with Urology Centers of Alabama ... the newly FDA-cleared procedure for qualifying patients. ... their expertise in the treatment of prostate cancer using many ...
(Date:2/5/2016)... February 5, 2016 --> ... report states that the global active pharmaceuticals ingredients (APIs) ... predicted to reach US$185.9 bn by 2020. It is ... 2014 to 2020. The title of the report is ... by Geography, and by Therapeutic Area) - Global Industry ...
(Date:2/5/2016)... -- Site Profile: --> ... Speech Recognition People, announced their latest primary healthcare case study where ... turnaround times and to save the practice money. Site ... Challenge: --> ,- Wirral CCG ,- VoicePower ... doctors ,- Wirral CCG ,- VoicePower client since 2013 ...
Breaking Medicine Technology:
(Date:2/5/2016)... Falls, NY & Salt Lake City, UT (PRWEB) , ... February ... ... Davis, Founder of Activz Whole-Food Nutrition , announced that the much-anticipated feature with ... on the New Really Cool Humans Amateur TV Network. , Each week, on his ...
(Date:2/5/2016)... York, New York (PRWEB) , ... February 05, 2016 , ... ... life? The answer may be at the tips of your toes. Foot massage, whether ... as well as pure comfort and relaxation. The American Board of Multiple Specialties ...
(Date:2/5/2016)... Chicago, Illinois (PRWEB) , ... February 05, 2016 ... ... advisors and independent PROSHRED franchises from across the country gathered at the La ... to recognize top performers. PROSHRED Chicago was named the year’s most outstanding ...
(Date:2/5/2016)... ... February 05, 2016 , ... Pivot Point ... Best in KLAS: Software & Services for HIT Implementation Support & Staffing report ... independently ranks vendor performance by healthcare executives, managers and clinicians representing over 4,500 ...
(Date:2/5/2016)... Viejo, CA (PRWEB) , ... February 05, 2016 , ... ... X. Move from on one drop zone to the next using Colorize's dynamic moving ... complements any project. This package includes a 3D slideshow environment with 1 to 5 ...
Breaking Medicine News(10 mins):